ArticleCancer discovery2022

Pharmacologic Inhibition of NT5C2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia.

Clara Reglero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.